| Literature DB >> 23139022 |
Angel Bottini1, Surya K De, Bas J G Baaten, Bainan Wu, Elisa Barile, Stephen Soonthornvacharin, John L Stebbins, Linda M Bradley, Sumit K Chanda, Maurizio Pellecchia.
Abstract
Successful replication of the influenza A virus requires both viral proteins and host cellular factors. In this study we used a cellular assay to screen for small molecules capable of interfering with any of such necessary viral or cellular components. We used an established reporter assay to assess influenza viral replication by monitoring the activity of co-expressed luciferase. We screened a diverse chemical compound library, resulting in the identification of compound 7, which inhibits a novel yet elusive target. Quantitative real-time PCR studies confirmed the dose-dependent inhibitory activity of compound 7 in a viral replication assay. Furthermore, we showed that compound 7 is effective in rescuing high-dose influenza infection in an in vivo mouse model. As oseltamivir-resistant influenza strains emerge, compound 7 could be further investigated as a new and potentially suitable scaffold for the development of anti-influenza agents that act on novel targets.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23139022 PMCID: PMC3769975 DOI: 10.1002/cmdc.201200453
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466